nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Associations of clinical features and prognosis with age at disease onset in patients with systemic lupus erythematosus
|
Feng, X |
|
2014 |
23 |
3 |
p. 327-334 |
artikel |
2 |
A surge in anti-dsDNA titer predicts a severe lupus flare within six months
|
Pan, N |
|
2014 |
23 |
3 |
p. 293-298 |
artikel |
3 |
Circulating FABP4 is a marker of metabolic and cardiovascular risk in SLE patients
|
Parra, S |
|
2014 |
23 |
3 |
p. 245-254 |
artikel |
4 |
Extremely hypotrophic newborn of mother with systemic lupus erythematosus and antiphospholipid syndrome
|
Mockova, A |
|
2014 |
23 |
3 |
p. 313-318 |
artikel |
5 |
Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis
|
Ni, J |
|
2014 |
23 |
3 |
p. 284-292 |
artikel |
6 |
Methotrexate in systemic lupus erythematosus: a systematic review of its efficacy
|
Sakthiswary, R |
|
2014 |
23 |
3 |
p. 225-235 |
artikel |
7 |
Mycophenolate mofetil in the treatment of SLE and systemic vasculitis: experience at a single university center
|
Lourdudoss, C |
|
2014 |
23 |
3 |
p. 299-304 |
artikel |
8 |
Podocyte injury in pure membranous and proliferative lupus nephritis: distinct underlying mechanisms of proteinuria?
|
Rezende, GM |
|
2014 |
23 |
3 |
p. 255-262 |
artikel |
9 |
Polypoidal choroidal vasculopathy and systemic lupus erythematosus
|
Chin, YC |
|
2014 |
23 |
3 |
p. 319-322 |
artikel |
10 |
Prediction of subclinical atherosclerosis by serum osteoprotegerin in premenopausal women with systemic lupus erythematous: correlation of osteoprotegerin with monocyte chemotactic protein-1
|
Park, Y-J |
|
2014 |
23 |
3 |
p. 236-244 |
artikel |
11 |
Severe multiorganic flare of systemic lupus erythematosus successfully treated with rituximab and cyclophosphamide avoiding high doses of prednisone
|
Gonzalez-Echavarri, C |
|
2014 |
23 |
3 |
p. 323-326 |
artikel |
12 |
Simultaneous changes in serum HMGB1 and IFN-α levels and in LAIR-1 expression on plasmatoid dendritic cells of patients with juvenile SLE.. New therapeutic options?
|
Kanakoudi-Tsakalidou, F |
|
2014 |
23 |
3 |
p. 305-312 |
artikel |
13 |
Synergistic effects of BuChE non-UU phenotype and paraoxonase (PON1) 55 M allele on the risk of systemic lupus erythematosus: influence on lipid and lipoprotein metabolism and oxidative stress, preliminary report
|
Bahrehmand, F |
|
2014 |
23 |
3 |
p. 263-272 |
artikel |
14 |
The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive disease
|
Khamashta, MA |
|
2014 |
23 |
3 |
p. 273-283 |
artikel |